482 related articles for article (PubMed ID: 17439496)
1. Behavioural and neural deficits induced by rotenone in the pond snail Lymnaea stagnalis. A possible model for Parkinson's disease in an invertebrate.
Vehovszky A; Szabó H; Hiripi L; Elliott CJ; Hernádi L
Eur J Neurosci; 2007 Apr; 25(7):2123-30. PubMed ID: 17439496
[TBL] [Abstract][Full Text] [Related]
2. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
3. Stability and variability of synapses in the adult molluskan CNS.
Magoski NS; Bulloch AG
J Neurobiol; 2000 Mar; 42(4):410-23. PubMed ID: 10699979
[TBL] [Abstract][Full Text] [Related]
4. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
5. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
[TBL] [Abstract][Full Text] [Related]
6. An identified central pattern-generating neuron co-ordinates sensory-motor components of respiratory behavior in Lymnaea.
Haque Z; Lee TK; Inoue T; Luk C; Hasan SU; Lukowiak K; Syed NI
Eur J Neurosci; 2006 Jan; 23(1):94-104. PubMed ID: 16420419
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
Radad K; Gille G; Rausch WD
Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
[TBL] [Abstract][Full Text] [Related]
9. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
[TBL] [Abstract][Full Text] [Related]
11. Neonicotinoid insecticides inhibit cholinergic neurotransmission in a molluscan (Lymnaea stagnalis) nervous system.
Vehovszky Á; Farkas A; Ács A; Stoliar O; Székács A; Mörtl M; Győri J
Aquat Toxicol; 2015 Oct; 167():172-9. PubMed ID: 26340121
[TBL] [Abstract][Full Text] [Related]
12. CREB in the pond snail Lymnaea stagnalis: cloning, gene expression, and function in identifiable neurons of the central nervous system.
Sadamoto H; Sato H; Kobayashi S; Murakami J; Aonuma H; Ando H; Fujito Y; Hamano K; Awaji M; Lukowiak K; Urano A; Ito E
J Neurobiol; 2004 Mar; 58(4):455-66. PubMed ID: 14978723
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic transmission between identified neurons from the mollusk, Lymnaea stagnalis.
Magoski NS; Bauce LG; Syed NI; Bulloch AG
J Neurophysiol; 1995 Sep; 74(3):1287-300. PubMed ID: 7500151
[TBL] [Abstract][Full Text] [Related]
14. Bioaccumulation and toxicity of aluminium in the pond snail at neutral pH.
McCrohan CR; Campbell MM; Jugdaohsingh R; Ballance S; Powell JJ; White KN
Acta Biol Hung; 2000; 51(2-4):309-16. PubMed ID: 11034154
[TBL] [Abstract][Full Text] [Related]
15. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
16. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
Schmidt WJ; Alam M
J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.
Klein A; Gidyk DC; Shriner AM; Colwell KL; Tatton NA; Tatton WG; Metz GA
Behav Brain Res; 2011 Sep; 222(1):33-42. PubMed ID: 21419806
[TBL] [Abstract][Full Text] [Related]
18. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.
Fleming SM; Zhu C; Fernagut PO; Mehta A; DiCarlo CD; Seaman RL; Chesselet MF
Exp Neurol; 2004 Jun; 187(2):418-29. PubMed ID: 15144868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
